High Proportion of Genome-Wide Homology and Increased Pretreatment <i>pvcrt</i> Levels in Plasmodium vivax Late Recurrences: a Chloroquine Therapeutic Efficacy Study
Eduard Rovira-Vallbona, Nguyen Van Hong, Johanna Helena Kattenberg, Ro Mah Huan, Nguyen Thi Huong Binh, Nguyen Thi Hong Ngọc, Pieter Guetens, Nguyen Luong Hieu, Nguyễn Thị Thu Hiền, Vũ Thị Sang, Nguyen Duc Long, Erin Sauve, Tran Thanh Duong, Nguyễn Xuân Xã, Annette Erhart, Anna Rosanas‐Urgell
Abstract
Chloroquine (CQ) is the first-line treatment for Plasmodium vivax malaria in most countries where malaria is endemic. Monitoring P. vivax CQ resistance (CQR) is critical but remains challenged by the difficulty to distinguish real treatment failure from reinfection or liver relapse.
Topics & Concepts
MalariaInterquartile rangePlasmodium vivaxChloroquineInternal medicineMedicinePlasmodium falciparumGastroenterologyGenotypingGenotypeBiologyVirologyImmunologyGeneticsGeneMalaria Research and ControlMosquito-borne diseases and controlDrug-Induced Hepatotoxicity and Protection